DrugPatentWatch Database Preview
Drugs in MeSH Category Chelating Agents
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Teva | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 207567-001 | Feb 7, 2018 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Valeant Pharms Intl | CUPRIMINE | penicillamine | CAPSULE;ORAL | 019853-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Recordati Rare | CHEMET | succimer | CAPSULE;ORAL | 019998-002 | Jan 30, 1991 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Mylan Speciality Lp | DEPEN | penicillamine | TABLET;ORAL | 019854-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| Watson Labs Inc | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 210976-001 | Jun 24, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
